EMPAGLIFLOZIN ATTENUATES CARDIAC MICROVASCULAR ISCHEMIA/REPERFUSION INJURY THROUGH IMPROVING MITOCHONDRIAL HOMEOSTASIS

Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis

Abstract Background Empagliflozin has been reported to protect endothelial cell function, regardless of diabetes status.However, the role of empagliflozin in microvascular protection during myocardial ischemia reperfusion injury (I/R) has not been chorulon hcg fully understood.Methods Electron microscopy, western blots, immunofluorescence, qPCR, mu

read more